Porovnať metódy

	Skóre sekvenčného hodnotenia orgánového zlyhania	Modifikovaný skóre včasného varovania	Skóre qSOFA
Odbor	Klinické hodnotenie	Klinické hodnotenie	Klinické hodnotenie
Rodina	Process / pipeline	Process / pipeline	Process / pipeline
Rok vzniku	1996	2001	2016
Tvorca	Jean-Louis Vincent and Rui Moreno	Christian P. Subbe, et al.	Sepsis-3 Taskforce
Typ	Organ dysfunction and sepsis assessment	Hospital ward deterioration warning system	Rapid sepsis screening
Pôvodný zdroj	Vincent, J. L., Moreno, R., Takala, J., et al. (1996). The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfuncti on/failure. Intensive Care Medicine, 22(7), 707-710.	Subbe, C. P., Kruger, M., Rutherford, P., & Gemmel, L. (2001). Validation of a modified Early Warning Score in medical admissions. QJM: An International Journal of Medicine, 94(10), 521-526.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Ďalšie názvy	SOFA, Sepsis-related Organ Failure Assessment	MEWS, Early warning score	Quick SOFA, qSOFA
Príbuzné	3	3	3
Zhrnutie	The Sequential Organ Failure Assessment (SOFA) score, introduced by Vincent and Moreno in 1996, is a 24-point daily assessment tool that quantifies organ dysfunction across six physiological systems in critically ill patients. It was adopted into the 2016 Sepsis-3 definitions and is now the international standard for identifying and grading sepsis-related organ failure.	The Modified Early Warning Score (MEWS), introduced by Subbe et al. in 2001, is a 14-point alert system designed for rapid detection of clinical deterioration in hospitalized patients. It combines six vital sign and laboratory parameters to identify patients at high risk of rapid decline, enabling early intervention before critical events occur.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.